METHOD FOR PREVENTING RECURRENCE AND METASTASIZING FOLLOWING ENDOPROSTHESIS REPLACEMENT IN MALIGNANT PRIMARY AND METASTATIC TUMORS OF BONES OF LOWER LIMBS

摘要

The method for preventing the recurrence and metastasizing following endoprosthesis replacement in the malignant primary and metastatic tumors of the bones of the lower limbs provides for the use of Mebifon in two days prior to the surgery and starting from the third postoperative day for three days at the conventional doses.